Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Cree BA, Bennett JL, Kim HJ, Weinshenker BG, et al. Sensitivity analysis of the primary endpoint from the N-MOmentum study of inebilizumab in NMOSD. Mult Scler 2021;27:2052-2061.
PMID: 33538237


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016